Stuart Kolinski, VP, General Counsel & Secretary at REGENERON PHARMACEUTICALS INC (REGN), sold 1,621 shares at $16.91 ($28K) on 2006-01-09, disclosed to the SEC on 2006-01-10.
Scheduled sale ($28k) by VP, General Counsel & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.87 | 13 | $219 | 0.8% |
| 2 | $16.88 | 16 | $270 | 1.0% |
| 3 | $16.91 | 53 | $896 | 3.2% |
| 4 | $16.92 | 61 | $1K | 3.7% |
| 5 | $16.98 | 53 | $900 | 3.2% |
| 6 | $16.99 | 133 |
| $2K |
| 8.0% |
| 7 | $17.00 | 20 | $340 | 1.2% |
| 8 | $17.01 | 73 | $1K | 4.4% |
| 9 | $17.02 | 133 | $2K | 8.1% |
| 10 | $17.04 | 14 | $239 | 0.8% |
| 11 | $17.14 | 80 | $1K | 4.9% |
| 12 | $17.50 | 67 | $1K | 4.2% |
| 13 | $17.52 | 27 | $473 | 1.7% |
| 14 | $17.53 | 153 | $3K | 9.5% |
| 15 | $17.54 | 40 | $702 | 2.5% |
| 16 | $17.55 | 8 | $140 | 0.5% |
| 17 | $17.56 | 186 | $3K | 11.6% |
| 18 | $17.57 | 280 | $5K | 17.5% |
| 19 | $17.58 | 171 | $3K | 10.7% |
| 20 | $17.60 | 40 | $704 | 2.5% |
| Total | $17.33 avg | 1,621 | $28K | 100% |
| Filing → |
| REGN | SELL | 2008-09-22 | $234K | — | Filing → |
| REGN | SELL | 2006-08-18 | $30K | — | Filing → |